Method for determining drug-sensitive human cell lines by analysis method in which measurement of activity of two types of protein kinase is used
US10995359B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2020 |
| Grant date | May 4, 2021 |
| Priority date | — |
| Expiry date | Jun 17, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91215
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention addresses the problem of providing a novel method for classifying cancer cells by an analysis method in which measurement of the activity of two types of protein kinase is used. Cancer cells are newly classified and drug sensitivity is predicted on the basis of the ratio of the activity of two types of protein kinase derived from the same sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.